Synergic cancer chemo-immunotherapy comprising combined doxorubicin and siRNA targeting CD47 co-delivered by a bola-amphiphilic dendrimer

Biomater. Sci., 2026, Accepted Manuscript
DOI: 10.1039/D6BM00031B, Paper

Open Access

&nbsp This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence.

Baoping Lian, Dandan Zhu, Peng Chen, Zhihui Wang, Fanzhen Meng, Ran Yan, Nikolay A Pyataev, Xiaoxuan Liu
Restoring antitumor immunity while enhancing chemotherapy efficacy represents an optimistic strategy for cancer treatment. Enabling macrophage-mediated phagocytosis of cancer cells is pivotal for rehabilitating effective immune responses.However, its efficacy is...
The content of this RSS Feed (c) The Royal Society of Chemistry